Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse? by Petek Üstün, Esra Adışen

Subjects: “…omalizumab…”
Get full text

A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data by A. S. Kolbin, L. S. Namazova-Baranova, E. A. Vishneva, M. Y. Frolov, T. L. Galankin, A. A. Alekseeva, E. A. Dobrynina

Subjects: Get full text

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients by A. Arrobas, M.P. Barbosa, S. Rabiais, B. Vandewalle, J. Félix

Subjects: Get full text

Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria by Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, Ezgi Sönmez, Yasemin Balaban, Mustafa İlker İnan, Özgür Kartal

Subjects: Get full text

Drug survival of omalizumab in atopic asthma: Impact of clinical and genetic variables by Susana Rojo-Tolosa, Alberto Caballero-Vázquez, Laura E. Pineda-Lancheros, José A. Sánchez-Martínez, María V. González-Gutiérrez, Gonzalo Jiménez-Gálvez, Alberto Jiménez-Morales, Concepción Morales-García

Subjects: Get full text

Comparative Analysis of ICS Combined with LABA versus Addition of Omalizumab on Transcriptomic Expression Profiles in Patients with Allergic Asthma by Liang YR, Chang CH, Huang SY, Wu YK, Yang MC, Huang KL, Tzeng IS, Hsieh PC, Lan CC

Subjects: Get full text

Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study by Vera G. Kalugina, Elena A. Vishneva, Leyla S. Namazova-Baranova

Subjects: Get full text

Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab by Liana Victory, MB, BCh, BAO, MRCPI, Gregg Murray, MB, BCh, BAO, MRCPI, Claire Quigley, MB, BCh, BAO, MRCPI, Stephanie Bowe, MD, MRCPI, Cliona Feighery, MB, BCh, BAO, Ann Fortune, MB, BCh, BAO, MRCPI, FRCPath, Ian McDonald, MD, MRCPI

Subjects: Get full text

Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma by Lu Min, Zhao Jing, Zeng Mei, Zhu AiMin, Li JinFen

Subjects: Get full text

Advances in omalizumab treatment for IgE-mediated food allergies by Siqi WANG, Ling YE, Meiling JIN

Subjects: Get full text

Dual biological treatments in immune-mediated disorders: a single center experience by Oded Shamriz, Elchanan Parnasa, Limor Rubin, Aviv Talmon, Yaarit Ribak, Isaam Hindi, Hagit Peleg, Ronit Confino-Cohen, Yuval Tal

Subjects: “…Omalizumab…”
Get full text

Omalizumab treatment can increase the serum levels of vitamin D in patients with chronic spontaneous urticaria by MENG Zhen, TANG Yaping

Subjects: Get full text

GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management by Torsten Zuberbier, Antonella Muraro, Ulugbek Nurmatov, Stefania Arasi, Katarina Stevanovic, Aikaterini Anagnostou, Roberta Bonaguro, Sharon Chinthrajah, Gideon Lack, Alessandro Fiocchi, Thuy‐My Le, Paul Turner, Montserrat Alvaro Lozano, Elizabeth Angier, Simona Barni, Phillippe Bégin, Barbara Ballmer‐Weber, Victoria Cardona, Carsten Bindslev‐Jensen, Antonella Cianferoni, Nicolette deJong, Debra deSilva, Antoine Deschildre, Audrey Dunn Galvin, Motohiro Ebisawa, David M. Fleischer, Jennifer Gerdts, Mattia Giovannini, Josefine Gradman, Susanne Halken, Syed Hasan Arshad, Ekaterina Khaleva, Susanne Lau, Richard Loh, Mika J. Mäkelä, Mary Jane Marchisotto, Laura Morandini, Charlotte G. Mortz, Caroline Nilsson, Anna Nowak‐Wegrzyn, Marcia Podestà, Lars K. Poulsen, Graham Roberts, Pablo Rodríguez del Río, Hugh A. Sampson, Angel Sánchez, Sabine Schnadt, Peter K. Smith, Hania Szajewska, Natasa Teovska Mitrevska, Alice Toniolo, Carina Venter, Amena Warner, Gary W. K. Wong, Robert Wood, Margitta Worm

Subjects: Get full text

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma by Manuel David Gil-Sierra, Leticia García-Mochón, Emilio Jesús Alegre-del Rey, Catalina Alarcón de la Lastra-Romero, Marina Sánchez-Hidalgo

Subjects: Get full text

Treatment of patients with evidence of mast cell-mediated itch in the absence of hives with omalizumab by Kelsey L. Auyeung, Brian S. Kim

Subjects: Get full text

A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database by Yongfu Song, Zhuang Wang, Na Wang, Xiaofei Xie, Tieshi Zhu, Yongji Wang

Subjects: “…Omalizumab…”
Get full text

Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis by Qian Wang, Hua Lei, Ge Yang, Ying Li, Wei Liu, Lixia Zhang, Xiyuan Zhou

Subjects: “…omalizumab…”
Get full text

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report by Tingrui Zhao, Yukai Chen, He Sun

Subjects: Get full text

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments by Riccardo Asero, Paolo Calzari, Silvia Vaienti, Massimo Cugno

Subjects: Get full text

ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES by V. S. Krysanova, E. D. Ermolaeva, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin

Subjects: Get full text